OUTLOOK THERAPEUTICS INC (OTLK)

Currency in USD
1.860
+0.020(+1.09%)
Closed·
1.970+0.110(+5.91%)
·
Unusual Post-Market activity
OTLK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.7901.920
52 wk Range
0.7903.390
Key Statistics
Prev. Close
1.86
Open
1.82
Day's Range
1.79-1.92
52 wk Range
0.79-3.39
Volume
2.98M
Average Volume (3m)
3.32M
1-Year Change
30.99%
Book Value / Share
-0.87
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OTLK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.750
Upside
+262.90%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period

OUTLOOK THERAPEUTICS INC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

OUTLOOK THERAPEUTICS Company Profile

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.

Compare OTLK to Peers and Sector

Metrics to compare
OTLK
Peers
Sector
Relationship
P/E Ratio
−2.7x−3.2x−0.6x
PEG Ratio
−0.03−0.110.00
Price/Book
−3.2x2.1x2.6x
Price / LTM Sales
79.2x206.2x3.2x
Upside (Analyst Target)
249.5%208.8%41.8%
Fair Value Upside
Unlock16.2%5.1%Unlock

Analyst Ratings

2 Buy
3 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 6.750
(+262.90% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Hold1.00-46.24%-Maintain30/09/2025
Brookline Capital Markets
Buy13.00+598.92%8.00Maintain29/09/2025
H.C. Wainwright
Hold1.00-46.24%3.00Downgrade29/08/2025
Guggenheim
Hold---Downgrade28/08/2025
Brookline Capital Markets
Buy10.00+437.63%11.00Maintain13/06/2025

Earnings

Latest Release
Dec 19, 2025
EPS / Forecast
-0.28 / -0.06
Revenue / Forecast
-92,320.00 / --
EPS Revisions
Last 90 days

People Also Watch

0.13
ZYXI
-36.46%
27.67
OLMA
-1.81%
1.3700
SNGX
+3.01%
2.430
CMND
-6.18%
0.6522
SLRX
-2.19%

FAQ

What Is the OUTLOOK THERAPEUTICS (OTLK) Share Price Today?

The live OUTLOOK THERAPEUTICS share price today is 1.860

What Stock Exchange Does OUTLOOK THERAPEUTICS (OTLK) Trade On?

OUTLOOK THERAPEUTICS is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for OUTLOOK THERAPEUTICS?

The stock symbol (also called a 'ticker') for OUTLOOK THERAPEUTICS is "OTLK."

What Is the Current OUTLOOK THERAPEUTICS Market Cap?

As of today, OUTLOOK THERAPEUTICS market capitalisation is 119.25M.

What Is OUTLOOK THERAPEUTICS's (OTLK) Earnings Per Share (TTM)?

The OUTLOOK THERAPEUTICS EPS is currently -1.79 (Trailing Twelve Months).

Is OTLK a Buy or Sell From a Technical Analyst Perspective?

Based on today's OUTLOOK THERAPEUTICS moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has OUTLOOK THERAPEUTICS Stock Split?

OUTLOOK THERAPEUTICS has split 2 times. (See the OTLK stock split history page for full effective split date and price information.)

How Many Employees Does OUTLOOK THERAPEUTICS Have?

OUTLOOK THERAPEUTICS has 23 employees.

What is the current trading status of OUTLOOK THERAPEUTICS (OTLK)?

As of 24 Dec 2025, OUTLOOK THERAPEUTICS (OTLK) is trading at a price of 1.860, with a previous close of 1.860. The stock has fluctuated within a day range of 1.790 to 1.920, while its 52-week range spans from 0.790 to 3.390.

What Is OUTLOOK THERAPEUTICS (OTLK) Price Target According to Analysts?

The average 12-month price target for OUTLOOK THERAPEUTICS is USD6.75, with a high estimate of USD13 and a low estimate of USD1. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +262.90% Upside potential.

What Is the OTLK After Hours Price?

OTLK's last after hours stock price is 1.970, the stock has decreased by 0.110, or 5.910%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.